Sustainable production of transgenic strawberry plants. ethnical consequences and potential effect on the producers and consumers.

Objective

The rationale for this project is given by the fact that the pharmaceutical industry is currently undergoing a significant change in strategy in preclinical drug development. Relevant advances are being made in the field of genome analysis with the onset of gene chip technologies permitting high throughput investigations and the use of miniature sample quantities. The same is happening for protease analysis and mass- spectrometry. We want to develop the "missing link" in high throughput testing: A highly controlled high-throughput bioreactor based on the use of engineered miniature in vitro tissue analogues. This will lead to the establishment of a firm correlation between genome, protease and catalytic expressions or biochemical function resulting in a complementary and more predictive picture of drug action.

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• engineering and technology › environmental biotechnology › bioremediation › bioreactors
• natural sciences › chemical sciences › analytical chemistry › mass spectrometry
• natural sciences › biological sciences › genetics › genomes

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-5. - Key action Sustainable Agriculture, Fisheries and Forestry

Call for proposal

Data not available

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Address

Ntnu
7491 Trondheim
Norway

Participants (2)

AACHEN UNIVERSITY OF TECHNOLOGY

Germany

Address

Eilfshornstrasse, 16
52056 Aachen

CENTRE FOR RURAL RESEARCH

Norway

Address

University Centre, Ntnu Dragvoll
7491 Trondheim